Georgia PGT Gene Screening Cost 2025: Latest Fee Structure & Influencing Factors

I. Georgia PGT Gene Screening Cost Structure and Reference Range

Georgia PGT (Preimplantation Genetic Testing) costs are tiered based on screening technology type, number of embryos, and laboratory accreditation. The following are the fee ranges for mainstream fertility centers in 2025. All prices are for a single biopsy and testing, excluding embryo freezing and transfer.

The above costs cover embryo biopsy, gene amplification, data analysis, and third-party laboratory testing reports. PGT-M and PGT-SR require building a family genetic model or custom probes first, hence their base cost is higher than PGT-A. Most Georgian fertility centers require at least 4–6 biopsiable blastocysts before initiating the testing process. If the number of blastocysts is insufficient, cumulative cycles or protocol adjustments may be necessary.

1.1 Included and Excluded Items

• Included: Embryo biopsy procedure fee, DNA amplification and library preparation, high-throughput sequencing (NGS) or array comparative genomic hybridization (aCGH) testing, genetic counselor data analysis, written report.
• Excluded: Ovulation induction medication costs, egg retrieval surgery fee, embryo freezing fee (typically $200–500/cycle), frozen embryo transfer fee, embryo transportation fee (if transfer to another center is required).
• Optional Add-ons: Mitochondrial DNA copy number assessment, chromosomal mosaicism analysis, additional embryo genetic counseling, each costing an extra $100–300.

II. Core Factors Influencing PGT Screening Costs

The total cost of PGT is not fixed; the following variables directly determine the final expenditure. Understanding these factors helps in setting reasonable cost expectations and avoiding budget overruns.

2.1 Choice of Screening Technology

PGT-A uses low-depth sequencing after whole genome amplification, with a standardized process and relatively controllable costs. PGT-M requires designing personalized primers or probes for specific gene loci, requiring prior testing of proband and parental samples. This preliminary work costs approximately $500–1,000, leading to a higher per-embryo cost. PGT-SR needs to identify breakpoint locations, with complexity similar to PGT-M, placing its cost in the mid-to-high range.

2.2 Number of Embryos Submitted for Testing

Most laboratories set a minimum billing base (e.g., 4 embryos), with additional embryos charged incrementally per embryo. For example, the total cost for testing 6 embryos is usually less than 1.5 times the cost for 4 embryos, as the fixed costs for library preparation and data analysis are spread out. Some centers offer an "all-blastocyst package" for a one-time fee of $3,000–5,000, regardless of the number submitted, suitable for patients expecting a larger number of blastocysts.

2.3 Laboratory Accreditation and Testing Platform

Costs differ between local Georgian laboratories and partnerships with overseas third-party labs (e.g., CAP-certified labs in Europe or Israel). Local labs typically charge 15%–25% less, but report turnaround times may be longer. Laboratories using NGS platforms have slightly lower per-embryo costs due to higher automation compared to aCGH platforms, though initial equipment investment keeps base fees similar.

2.4 Timing of Embryo Biopsy

Day 5 or Day 6 blastocyst biopsy is the standard. Some centers delay biopsy for slower-growing blastocysts to Day 7, incurring an additional culture fee of $200–400, and increased biopsy difficulty may affect testing success rates.

2.5 Genetic Counseling and Report Interpretation

PGT reports involve complex information like chromosomal copy number variations, mosaicism ratios, and pathogenicity of single gene loci. The cost of professional genetic counselor report interpretation is usually included in the testing fee. Additional consultations or third-party reviews cost $150–300 each.

III. Cost Differences Between Georgia and Other Countries

A core motivation for patients choosing Georgia for PGT screening is cost-effectiveness. The following comparison is based on publicly available 2025 fee data, all in USD.

Georgia's cost advantage mainly stems from lower salary levels for doctors and lab technicians compared to Western Europe and the US, lower institutional operating costs, and no additional "international patient surcharge." However, be aware that some low-cost packages may not include embryo freezing fees, initial genetic counseling fees, or report translation fees. Confirm each item before signing the contract.

IV. Easily Overlooked Cost Details

According to practitioner observations, over 60% of patients underestimate the following three types of expenses during their initial budgeting, leading to the need for additional funds mid-cycle.

4.1 Embryo Freezing and Storage Fees

After PGT results are available, transferable embryos need to be frozen and stored until the transfer cycle. Georgian fertility centers typically charge annual freezing fees, ranging from $500–1,000 per year, with some centers offering the first year free. If patients need to transport embryos to another center, transportation costs are additional, around $800–1,200.

4.2 Probe Preparation or Family Pre-testing Fees

Before PGT-M and PGT-SR testing, peripheral blood samples from the patient and immediate family members (usually parents or children) are needed for pre-testing to confirm the pathogenic locus or breakpoint. This step costs approximately $800–1,500 and is non-refundable regardless of whether embryos are subsequently tested. Some patients mistakenly believe this fee is included in the total price, but it is a separate charge.

4.3 Additional Embryo Biopsy Fees

If the number of blastocysts exceeds expectations and the patient wishes to test all of them to select the best embryo, embryos beyond the package quantity incur an additional biopsy fee, typically $150–300 per embryo. Additionally, the freezing of biopsied embryos is also billed separately.

4.4 Report Translation and Certification Fees

PGT reports from Georgian fertility centers are often in Russian or Georgian. International patients requiring English or Chinese versions may pay translation and notarization fees of $100–300. Some countries (e.g., China) require embassy certification of the report for subsequent medical or legal use, incurring additional certification costs.

V. Common Cost Traps in PGT Screening

The following situations are frequently mentioned in daily practitioner consultations. Understanding these traps can help patients avoid unnecessary financial losses.

5.1 "All-Inclusive Price" Is Not Always All-Inclusive

Some institutions offer "PGT all-inclusive" packages, but a careful reading of the terms reveals that the price applies only to a specific number of embryos (e.g., 4), with excess embryos charged at a higher rate; or it may not include embryo freezing fees or ovulation induction medication costs. Before signing, request a complete fee schedule clarifying what is included and excluded.

5.2 Low-Price Bait Followed by Add-Ons

A few centers attract patients with extremely low PGT-A prices (e.g., $199/embryo). After the patient completes ovulation induction and egg retrieval, they are informed of additional charges for "embryo culture upgrade," "time-lapse imaging monitoring," "laboratory usage fees," etc., resulting in a total cost similar to or even higher than standard quotes.

5.3 Charges for Failed or Inconclusive Results

Approximately 5%–10% of embryos fail to produce a report due to DNA amplification failure or substandard data quality. Some centers charge the full testing fee for failed cases, or half the biopsy fee. It is advisable to clearly stipulate refund or reduction policies for testing failures in the contract.

5.4 Cross-Border Payments and Exchange Rate Fluctuations

The local currency in Georgia is the Lari (GEL), but fertility centers usually quote and accept payments in USD. If patients remit via domestic banks, they may incur transfer fees ($15–50 per transaction) and exchange rate losses (approximately 1%–3%). It is recommended to pay directly in USD cash to reduce intermediate conversion costs.

VI. Actual Process and Payment Milestones for PGT Screening in Georgia

Understanding the correspondence between the process and payment milestones helps patients prepare funds in stages and avoid temporary financial pressure.

1. Initial Consultation and Genetic Counseling (Cost: $0–200): Some centers offer free online consultations; fees apply for formal genetic counseling reports. Confirm whether the patient needs PGT-M or PGT-SR and initiate family pre-testing.
2. Ovulation Induction and Egg Retrieval (Cost: $3,000–6,000): This stage primarily covers medication, ultrasound monitoring, egg retrieval surgery, and anesthesia. PGT testing fees are not yet incurred.
3. Embryo Culture and Blastocyst Formation (Cost: Included in cycle fee): The lab performs blastocyst culture, assessing biopsy feasibility on Days 5–7. The number of embryos for testing can be determined at this point.
4. Embryo Biopsy and Submission (Cost: PGT testing fee paid per embryo): Sign the PGT informed consent form and pay the testing fee. The center codes and sends biopsy samples to the lab.
5. Testing Analysis and Report Issuance (Duration: 14–21 days): The lab completes NGS or aCGH testing and issues a report containing chromosomal copy number and gene locus information.
6. Genetic Counseling and Transfer Decision (Cost: Included or additional $150–300): The doctor or genetic counselor interprets the report to determine transferable embryos. A second consultation or third-party review incurs extra charges.
7. Embryo Freezing and Storage (Cost: $200–500/year): Transferable embryos are frozen and stored pending endometrial preparation for transfer. Freezing fees are typically paid annually.
8. Frozen Embryo Transfer (Cost: $1,500–3,000): Includes endometrial preparation, transfer procedure, and luteal phase support medication. This cost is independent of PGT testing.

Payment milestones are mainly concentrated at Step 4 (biopsy submission) and Step 7 (freezing storage), with these two stages accounting for over 70% of total PGT-related expenses.

VII. Compilation of Frequently Asked Questions

7.1 Can PGT screening in Georgia be done on just 1 embryo?

Technically yes, but it is not recommended from a cost-efficiency perspective. The per-embryo cost for a single embryo is the highest (approximately $600–1,200), and if that embryo tests abnormal, the entire cycle yields no usable embryo. Most centers recommend testing at least 4 embryos to increase the probability of obtaining a transferable embryo.

7.2 Why does miscarriage still occur after a normal PGT-A screening?

PGT-A only screens for chromosomal aneuploidies; it cannot detect monogenic diseases, methylation abnormalities, mitochondrial disorders, or endometrial receptivity issues. Approximately 30%–40% of miscarriages are unrelated to chromosomes, so PGT-A cannot completely eliminate miscarriage risk.

7.3 Are Georgian PGT reports accepted by domestic hospitals?

Reproductive centers in major Chinese tertiary hospitals generally accept PGT reports from accredited Georgian laboratories, but may require an English version or embassy certification. It is advisable to confirm specific requirements with your domestic doctor in advance.

7.4 Is another PGT test needed before frozen embryo transfer?

No. PGT results remain stable during embryo freezing; no repeat testing is needed before transfer. However, it is necessary to confirm the embryo's frozen status is good, as post-thaw survival is unrelated to PGT results.

7.5 Who is suitable for choosing Georgia for PGT?

Suitable for: individuals over 35, those with a history of recurrent implantation failure or recurrent miscarriage, carriers of known monogenic disorders, carriers of chromosomal balanced translocations, and families wishing to reduce the risk of embryonic chromosomal abnormalities. Not suitable for patients with severe uterine abnormalities, uncontrolled autoimmune diseases, or severe mental illness.

7.6 What materials are needed for PGT in Georgia?

Passport, previous fertility and genetic history records, both partners' karyotype analysis reports (if available), and a confirmed diagnosis report for the family genetic disease proband (applicable for PGT-M). Some centers require infectious disease screening results (HIV, Hepatitis B, Hepatitis C, Syphilis) from within the last 3 months.

VIII. Practitioner Observations: How to Reasonably Plan PGT Cost Budget

Based on over 300 Georgian PGT cases handled in the past 5 years, the following suggestions can serve as a reference for cost planning.

8.1 Recommended Budget Range

A complete Georgian PGT cycle (ovulation induction + egg retrieval + PGT-A + freezing + first transfer) totals approximately $8,000–14,000. If PGT-M or PGT-SR is involved, the total cost increases by 30%–50%. It is recommended that patients prepare $12,000–18,000 in liquid funds to cover all possible scenarios.

8.2 Cost Control Strategies

• Choose centers with close local lab partnerships: Reduce third-party intermediary costs and shorten testing cycles.
• Submit a sufficient number of embryos in one batch: Avoid repeated ovulation induction and biopsy costs from cumulative cycles.
• Clarify the included freezing period: Some centers offer "first year free freezing" or "three-year discount for one-time payment" policies.
• Avoid unnecessary additional tests: Mitochondrial DNA copy number assessment and detailed mosaicism analysis have limited clinical value for most patients; consider them selectively based on doctor's advice.

8.3 Managing Psychological Expectations

The purpose of PGT screening is to select chromosomally normal embryos, but not all patients will obtain usable embryos. In about 15%–25% of cycles, all embryos are abnormal, resulting in no embryo for transfer. This testing cost is a "screening cost." Even if no transferable embryo is obtained, the testing itself provides important genetic information, preventing miscarriage or birth defects from transferring abnormal embryos.

Risk Reminder

PGT technology cannot detect all genetic abnormalities with 100% accuracy. Mosaic embryos (mixtures of normal and abnormal cells) may be misclassified as normal or abnormal, potentially leading to miscarriage or abnormal pregnancy after transfer. PGT-M testing requires clear proband diagnostic information; if the family genetic model is incomplete, the accuracy of test results decreases. Additionally, embryo biopsy is an invasive procedure that may affect embryo developmental potential, though clinical data show no significant negative impact on blastocyst implantation rates. All cost planning should be based on written contracts; verbal promises have no legal effect. Patients are advised to keep all payment receipts and test reports for future medical or legal needs.